OK MPJE cheat sheet

Combat Methamphetamine Epidemic Act: retail sales of ephedrine/pseudoephedrine are limited to 3.6 g per purchaser per day and 9 g per 30-day period, sold from behind the counter with photo ID and a written logbook.

Durham-Humphrey Amendment created the prescription ('legend') class; legend drugs require prescriber authorization to dispense and to refill, and OTC drugs do not.

Poison Prevention Packaging Act: child-resistant packaging is required for oral prescription drugs unless the prescriber directs otherwise in writing or the patient requests non-child-resistant packaging.

OBRA 1990 requires state Medicaid programs to mandate that pharmacies offer counseling and perform prospective and retrospective drug utilization review.

Oklahoma's Pharmacy Practice Act is codified at Title 59 O.S. Section 353 et seq.; implementing Board of Pharmacy rules appear in Title 535 of the Oklahoma Administrative Code.

Controlled substance records, including prescriptions, invoices, inventories, and DEA order forms, must be kept at least two years under federal regulation and produced for inspection.

Schedule II prescriptions may not be refilled; Schedule III-V prescriptions may be refilled only within six months of the date of issue and only up to the number of refills authorized.

HIPAA allows disclosure of protected health information without authorization for treatment, payment, and health care operations; other disclosures generally require a signed authorization.

The prescriber and the dispensing pharmacist share corresponding responsibility: a controlled substance order must be issued for a legitimate medical purpose in the usual course of professional practice.

Each physical pharmacy location must hold a current pharmacy license issued by the Oklahoma State Board of Pharmacy before dispensing begins.

Oklahoma requires two separate controlled substance registrations: a federal DEA registration and a state registration issued by the Oklahoma Bureau of Narcotics and Dangerous Drugs Control (OBNDD).

DEA form mapping: Form 224 is a new registration application, 224a is a renewal, 106 is a theft or loss report, 41 documents destruction, and 222 (or CSOS) orders Schedule II drugs.

DEA registrations are valid for three years; a registration must be renewed before its expiration date to preserve dispensing authority.

A pharmacist license in Oklahoma requires graduation from an accredited program, passing NAPLEX and MPJE, completion of internship hours, and a Board application.

The prescription department must be under the supervision of a licensed Oklahoma pharmacist at all times the pharmacy is open for business.

A change in the pharmacist-in-charge must be reported to the Board within the timeframe set by Board rule, and the DEA must be notified of changes in the registrant's name, address, or ownership.

Out-of-state pharmacists obtain Oklahoma licensure by score transfer or reciprocity and must pass the Oklahoma MPJE before a license is issued.

A valid prescription must contain the patient name and address, drug name, strength, dosage form, quantity, directions, date of issue, prescriber name, address, DEA number when controlled, and prescriber signature.

Schedule II prescriptions expire without refill authority; Schedule III-V prescriptions permit up to five refills within six months of the issue date.

Emergency oral Schedule II orders are limited to the quantity needed for the emergency period, and the prescriber must deliver a written prescription within seven days or the pharmacist must notify DEA.

Generic substitution is permitted unless the prescriber writes 'dispense as written' or the patient refuses substitution; the pharmacist must notify the patient as state law requires.

A prescriber must hold a valid state license, hold a DEA registration for controlled substances, and act within the scope of that license.

Oklahoma allows pharmacists to dispense naloxone without a patient-specific prescription under a statewide standing order and to administer immunizations under a protocol.

Advanced practice registered nurses and physician assistants prescribe within a collaborative or supervisory relationship defined by Oklahoma statute, and their authority for controlled substances is limited by law.

The final verification of a filled prescription is a pharmacist function and may not be delegated to a pharmacy technician.

Schedule II purchases require DEA Form 222 or an approved CSOS electronic order; Schedule III-V purchases require invoices, which serve as the receipt record.

An initial inventory is required at registration and a biennial inventory every two years thereafter; Schedule II items are counted exactly and the date, time, and open or closed status are recorded.

Partial filling of a Schedule II prescription is allowed when the pharmacist cannot supply the full quantity, with the remainder supplied within 72 hours; for long-term care residents or terminally ill patients the remainder may be supplied within 60 days.

Theft or significant loss of controlled substances must be reported to DEA in writing on Form 106 within one business day of discovery, with parallel notice to state and local authorities.

Destruction of controlled substances is documented on DEA Form 41, typically through a registered reverse distributor or a witnessed destruction process.

Electronic CSOS ordering requires a digitally signed certificate issued to each authorized signer, and paper Form 222 signers require a power of attorney filed with the supplier.

Pharmacies must report controlled substance dispensing to the Oklahoma Prescription Monitoring Program, which is administered by OBNDD.

A DEA registration does not authorize dispensing outside the usual course of professional practice; red flags such as early refills, distant patients, or cash payment must be resolved before dispensing.

Schedule II prescriptions are filed separately from other prescriptions; Schedule III-V prescriptions are filed separately or maintained so they are readily retrievable, and all are kept at least two years.

Labels must show the pharmacy name and address, prescription number, date, patient name, prescriber, directions, quantity, refills authorized, required cautionary statements, and beyond-use or expiration information.

Compounding follows USP 795 for nonsterile preparations and USP 797 for sterile preparations, which govern facilities, environmental monitoring, personnel training, and beyond-use dating.

Pharmacy technicians work under direct pharmacist supervision and may not counsel patients, exercise independent professional judgment, or perform the final check of a filled prescription.

The pharmacy must maintain an ongoing quality improvement and medication error prevention program with documentation of error reviews and corrective actions.

Outdated, expired, adulterated, or misbranded drugs must be removed from active stock and quarantined pending return or destruction.

Prescriptions, inventories, invoices, order forms, and inspection reports must be produced for Board or DEA inspection during business hours.

The pharmacist-in-charge is accountable for compliance, staff training, security of the prescription department, and completeness of the required records at that licensed location.

The pharmacist must offer counseling on every new and refill prescription, and the offer and any refusal should be documented in the patient record to satisfy OBRA 1990.

Prospective drug utilization review screens for therapeutic duplication, drug interactions, allergies, incorrect dose or duration, and abuse or misuse, and the pharmacist resolves each alert before dispensing.

Oklahoma's Prescription Monitoring Program is administered by OBNDD; dispensers submit controlled substance dispensing data and pharmacists may query the database when assessing a patient.

Oklahoma law limits an initial opioid prescription written for acute pain to a seven-day supply, subject to statutory exceptions.

Naloxone may be dispensed without a patient-specific prescription under Oklahoma's standing order; the patient or caregiver receives instructions on recognizing overdose and calling emergency services.

Pharmacists who administer immunizations must document the vaccine, dose, date, site, lot, and manufacturer, give the patient a record, and report to the Oklahoma immunization registry (OSIIS).

Medication guides, patient package inserts, and REMS-related materials must be provided whenever the FDA-approved labeling requires them.

Child-resistant packaging, proper storage counseling, and drug take-back or disposal instructions reduce accidental poisoning and diversion risk.